Testing Nivolumab as a Potential Targeted Treatment in Cancers With Mismatch Repair Deficiency (MATCH-Subprotocol Z1D)
Clinical trial NCT04439214 · COMPLETED
Trial details
- NCT number
- NCT04439214
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-31
- Primary completion
- 2018-10-11
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.